Trump suggests Pfizer could win US Covid-19 vaccine approval, JNJ to come later
Trump also cited efforts by Moderna Inc and AstraZeneca Plc
US President Donald Trump on Monday suggested Pfizer Inc could secure the first US approval of a Covid-19 vaccine in coming weeks, saying a contender by Johnson & Johnson could come later.
Asked which drugmaker could be approved, Trump told Fox News in an interview: "Pfizer's doing really well," adding "Johnson & Johnson ... they'll probably be a little later."
He also cited efforts by Moderna Inc and AstraZeneca Plc.